158 related articles for article (PubMed ID: 36474172)
1. Interactions between the apolipoprotein E4 gene and modifiable risk factors for cognitive impairment: a nationally representative panel study.
Kolli A; Zhou Y; Chung G; Ware EB; Langa KM; Ehrlich JR
BMC Geriatr; 2022 Dec; 22(1):938. PubMed ID: 36474172
[TBL] [Abstract][Full Text] [Related]
2. Subjective cognitive decline, APOE e4 allele, and the risk of neurocognitive disorders: Age- and sex-stratified cohort study.
Liew TM
Aust N Z J Psychiatry; 2022 Dec; 56(12):1664-1675. PubMed ID: 35229693
[TBL] [Abstract][Full Text] [Related]
3. Physical activity modifies the influence of apolipoprotein E ε4 allele and type 2 diabetes on dementia and cognitive impairment among older Mexican Americans.
Shih IF; Paul K; Haan M; Yu Y; Ritz B
Alzheimers Dement; 2018 Jan; 14(1):1-9. PubMed ID: 28692819
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychiatric symptoms, APOE ε4, and the risk of incident dementia: a population-based study.
Pink A; Stokin GB; Bartley MM; Roberts RO; Sochor O; Machulda MM; Krell-Roesch J; Knopman DS; Acosta JI; Christianson TJ; Pankratz VS; Mielke MM; Petersen RC; Geda YE
Neurology; 2015 Mar; 84(9):935-43. PubMed ID: 25653291
[TBL] [Abstract][Full Text] [Related]
5. Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.
Krell-Roesch J; Vemuri P; Pink A; Roberts RO; Stokin GB; Mielke MM; Christianson TJ; Knopman DS; Petersen RC; Kremers WK; Geda YE
JAMA Neurol; 2017 Mar; 74(3):332-338. PubMed ID: 28135351
[TBL] [Abstract][Full Text] [Related]
6. Education and the moderating roles of age, sex, ethnicity and apolipoprotein epsilon 4 on the risk of cognitive impairment.
Makkar SR; Lipnicki DM; Crawford JD; Kochan NA; Castro-Costa E; Lima-Costa MF; Diniz BS; Brayne C; Stephan B; Matthews F; Llibre-Rodriguez JJ; Llibre-Guerra JJ; Valhuerdi-Cepero AJ; Lipton RB; Katz MJ; Zammit A; Ritchie K; Carles S; Carriere I; Scarmeas N; Yannakoulia M; Kosmidis M; Lam L; Fung A; Chan WC; Guaita A; Vaccaro R; Davin A; Kim KW; Han JW; Suh SW; Riedel-Heller SG; Roehr S; Pabst A; Ganguli M; Hughes TF; Jacobsen EP; Anstey KJ; Cherbuin N; Haan MN; Aiello AE; Dang K; Kumagai S; Narazaki K; Chen S; Ng TP; Gao Q; Nyunt MSZ; Meguro K; Yamaguchi S; Ishii H; Lobo A; Lobo Escolar E; De la Cámara C; Brodaty H; Trollor JN; Leung Y; Lo JW; Sachdev P;
Arch Gerontol Geriatr; 2020; 91():104112. PubMed ID: 32738518
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline.
Beydoun MA; Boueiz A; Abougergi MS; Kitner-Triolo MH; Beydoun HA; Resnick SM; O'Brien R; Zonderman AB
Neurobiol Aging; 2012 Apr; 33(4):720-731.e4. PubMed ID: 20619505
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E4 Allele and Gait Performance in Mild Cognitive Impairment: Results From the Gait and Brain Study.
Sakurai R; Montero-Odasso M
J Gerontol A Biol Sci Med Sci; 2017 Nov; 72(12):1676-1682. PubMed ID: 28482102
[TBL] [Abstract][Full Text] [Related]
9. Association of APOE ε4 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: A cross-sectional study.
Jin X; He W; Zhang Y; Gong E; Niu Z; Ji J; Li Y; Zeng Y; Yan LL
PLoS Med; 2021 Jun; 18(6):e1003597. PubMed ID: 34061824
[TBL] [Abstract][Full Text] [Related]
10. Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study.
Low A; Prats-Sedano MA; McKiernan E; Carter SF; Stefaniak JD; Nannoni S; Su L; Dounavi ME; Muniz-Terrera G; Ritchie K; Lawlor B; Naci L; Malhotra P; Mackay C; Koychev I; Ritchie CW; Markus HS; O'Brien JT
Alzheimers Res Ther; 2022 Oct; 14(1):154. PubMed ID: 36224605
[TBL] [Abstract][Full Text] [Related]
11. Association of Unhealthy Lifestyle and Genetic Risk Factors With Mild Cognitive Impairment in Chinese Older Adults.
Duan H; Zhou D; Xu N; Yang T; Wu Q; Wang Z; Sun Y; Li Z; Li W; Ma F; Chen Y; Du Y; Zhang M; Yan J; Sun C; Wang G; Huang G
JAMA Netw Open; 2023 Jul; 6(7):e2324031. PubMed ID: 37462970
[TBL] [Abstract][Full Text] [Related]
12. Timing of Physical Activity, Apolipoprotein E ε4 Genotype, and Risk of Incident Mild Cognitive Impairment.
Krell-Roesch J; Pink A; Roberts RO; Stokin GB; Mielke MM; Spangehl KA; Bartley MM; Knopman DS; Christianson TJ; Petersen RC; Geda YE
J Am Geriatr Soc; 2016 Dec; 64(12):2479-2486. PubMed ID: 27801933
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype.
Haan MN; Aiello AE; West NA; Jagust WJ
Neurobiol Aging; 2008 Dec; 29(12):1774-82. PubMed ID: 17540481
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
[TBL] [Abstract][Full Text] [Related]
15. Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.
Belloy ME; Napolioni V; Han SS; Le Guen Y; Greicius MD;
JAMA Neurol; 2020 Jul; 77(7):849-862. PubMed ID: 32282020
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E genotype and physical function among older people with mild cognitive impairment.
Doi T; Shimada H; Makizako H; Tsutsumimoto K; Uemura K; Suzuki T
Geriatr Gerontol Int; 2015 Apr; 15(4):422-7. PubMed ID: 24730603
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E ε4 allele is associated with vascular cognitive impairment no dementia in Chinese population.
Han Y; Zhou A; Li F; Wang Q; Xu L; Jia J
J Neurol Sci; 2020 Feb; 409():116606. PubMed ID: 31865187
[TBL] [Abstract][Full Text] [Related]
18. Association of a wide range of chronic diseases and apolipoprotein E4 genotype with subsequent risk of dementia in community-dwelling adults: A retrospective cohort study.
Shang X; Zhu Z; Zhang X; Huang Y; Zhang X; Liu J; Wang W; Tang S; Yu H; Ge Z; Yang X; He M
EClinicalMedicine; 2022 Mar; 45():101335. PubMed ID: 35299656
[TBL] [Abstract][Full Text] [Related]
19. The role of dementia in the association between APOE4 and all-cause mortality: pooled analyses of two population-based cohort studies.
Régy M; Dugravot A; Sabia S; Helmer C; Tzourio C; Hanseeuw B; Singh-Manoux A; Dumurgier J
Lancet Healthy Longev; 2024 Jun; 5(6):e422-e430. PubMed ID: 38824957
[TBL] [Abstract][Full Text] [Related]
20. Effects of functional variants of vitamin C transporter genes on apolipoprotein E E4-associated risk of cognitive decline: The Nakajima study.
Hayashi K; Noguchi-Shinohara M; Sato T; Hosomichi K; Kannon T; Abe C; Domoto C; Yuki-Nozaki S; Mori A; Horimoto M; Yokogawa M; Sakai K; Iwasa K; Komai K; Ishimiya M; Nakamura H; Ishida N; Suga Y; Ishizaki J; Ishigami A; Tajima A; Yamada M
PLoS One; 2021; 16(11):e0259663. PubMed ID: 34780525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
